173 related articles for article (PubMed ID: 17644310)
1. COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia.
Bertolino A; Caforio G; Blasi G; Rampino A; Nardini M; Weinberger DR; Dallapiccola B; Sinibaldi L; Douzgou S
Schizophr Res; 2007 Sep; 95(1-3):253-5. PubMed ID: 17644310
[No Abstract] [Full Text] [Related]
2. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
[TBL] [Abstract][Full Text] [Related]
3. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
[TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
[TBL] [Abstract][Full Text] [Related]
5. COMT158 polymorphism and hostility.
Volavka J; Kennedy JL; Ni X; Czobor P; Nolan K; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Lieberman JA
Am J Med Genet B Neuropsychiatr Genet; 2004 May; 127B(1):28-9. PubMed ID: 15108175
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
Galderisi S; Maj M; Kirkpatrick B; Piccardi P; Mucci A; Invernizzi G; Rossi A; Pini S; Vita A; Cassano P; Stratta P; Severino G; Del Zompo M
Neuropsychobiology; 2005; 52(2):83-9. PubMed ID: 16037677
[TBL] [Abstract][Full Text] [Related]
7. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
[TBL] [Abstract][Full Text] [Related]
8. Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia.
Docherty AR; Sponheim SR
J Abnorm Psychol; 2008 Nov; 117(4):788-98. PubMed ID: 19025226
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
[TBL] [Abstract][Full Text] [Related]
10. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder.
Goghari VM; Sponheim SR
Schizophr Res; 2008 Aug; 103(1-3):186-91. PubMed ID: 18571901
[TBL] [Abstract][Full Text] [Related]
11. Association study of a functional catechol-O-methyltransferase genetic polymorphism with age of onset, cognitive function, symptomatology and prognosis in chronic schizophrenia.
Tsai SJ; Hong CJ; Liao DL; Lai IC; Liou YJ
Neuropsychobiology; 2004; 49(4):196-200. PubMed ID: 15118357
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
Kim YR; Kim JH; Kim SJ; Lee D; Min SK
Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
[TBL] [Abstract][Full Text] [Related]
13. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
Carrà G; Nicolini G; Crocamo C; Lax A; Amidani F; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Papagno C; Clerici M
Nord J Psychiatry; 2017 Jul; 71(5):332-339. PubMed ID: 28635556
[TBL] [Abstract][Full Text] [Related]
14. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
[TBL] [Abstract][Full Text] [Related]
15. Interaction of catechol-O-methyltransferase (COMT) Val108/158 Met genotype and risperidone treatment in Chinese Han patients with schizophrenia.
Kang CY; Xu XF; Shi ZY; Yang JZ; Liu H; Xu HH
Psychiatry Res; 2010 Mar; 176(1):94-5. PubMed ID: 20053459
[No Abstract] [Full Text] [Related]
16. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
[TBL] [Abstract][Full Text] [Related]
17. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.
Xu H; Kellendonk CB; Simpson EH; Keilp JG; Bruder GE; Polan HJ; Kandel ER; Gilliam TC
Schizophr Res; 2007 Feb; 90(1-3):104-7. PubMed ID: 17113268
[TBL] [Abstract][Full Text] [Related]
18. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
Woodward ND; Jayathilake K; Meltzer HY
Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
[TBL] [Abstract][Full Text] [Related]
20. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients.
Han DH; Kee BS; Min KJ; Lee YS; Na C; Park DB; Lyoo IK
Neuroreport; 2006 Jan; 17(1):95-9. PubMed ID: 16361958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
